| Literature DB >> 31754307 |
Setareh Mamishi1,2, Shima Mahmoudi2, Naimeh Naserzadeh1, Reihaneh Hosseinpour Sadeghi2, Mohammad Taghi Haghi Ashtiani3, Abbas Bahador4, Mohammad Reza Abdosalehi1, Maryam Rahmani5, Babak Pourakbari2.
Abstract
BACKGROUND AND AIM: Hospital-acquired infection (HAI) is a major problem worldwide. Understanding patterns of bacterial etiology and antibiotic susceptibility is vital to combating HAI. Besides, typing of isolates is important to establish the intra-hospital surveillance of resistant clones. In this study, we aimed to evaluate antibiotic resistance and genotyping of a number of gram-negative bacteria (GNB) causing HAI in patients who were referred to Children's Medical Center.Entities:
Keywords: antibiotic resistance; gram-negative bacteria; hospital-acquired infection
Year: 2019 PMID: 31754307 PMCID: PMC6825472 DOI: 10.2147/IDR.S195126
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Characteristics of studied patients
| Characteristics | N (%) | |
|---|---|---|
| Gender | Male | 84 (59.2) |
| Female | 58 (40.8) | |
| Age (years) | <1 | 71 (50) |
| 1–5 | 45 (31.7) | |
| >5 | 26 (18.3) | |
| Ward | Surgical | 19 (13) |
| Emergency | 17 (12) | |
| EPICU | 14 (10) | |
| NICU | 13 (9) | |
| PICU | 12 (8.5) | |
| NICU OPH | 10 (7) | |
| Nephrology | 8 (6) | |
| Oncology | 8 (6) | |
| Infectious | 7 (5) | |
| Gastroenterology | 7 (5) | |
| CICU | 7 (5) | |
| Rheumatology | 5 (3.5) | |
| Neonatal | 4 (3) | |
| IICU | 3 (2) | |
| Urology | 3 (2) | |
| Neurology | 2 (1) | |
| Cardiology | 2 (1) | |
| Transplant | 1 (0.7) | |
Abbreviations: EPICU, Emergency Intensive Care Unit; NICU, Neonatal Intensive Care Unit; PICU, Pediatric Intensive Care Unit; OPH, Ophthalmology; CICU, Cardiac Intensive Care Unit; IICU, Intermediate Intensive Care Unit.
Frequency of occurrence of GNB isolated from blood, wounds, and sterile body fluid cultures
| Sample | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
| Blood | 15 (17) | 19 (21) | 2 (2) | 15 (17) | 10 (11) | 11 (12) | 6 (7) | 4 (4) | 6 (7) | 1 (1) | 1 (1) | 90 (63) |
| Wound | 6 (30) | 2 (10.5) | 1 (5) | 0 (0) | 2 (10.5) | 0 (0) | 2 (10.5) | 0 (0) | 7 (37) | 0 (0) | 0 (0) | 20 (13.7) |
| Abdominal fluid | 8 (89) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (12.5) | 0 (0) | 0 (0) | 9 (6.7) |
| CSF | 2 (25) | 2 (25) | 0 (0) | 2 (25) | 0 (0) | 0 (0) | 0 (0) | 1 (12.5) | 1 (12.5) | 0 (0) | 0 (0) | 8 (6) |
| Central venous catheter tip | 0 (0) | 2 (28.5) | 0 (0) | 0 (0) | 2 (28.5) | 0 (0) | 2 (28.5) | 1 (14) | 0 (0) | 0 (0) | 0 (0) | 7 (5) |
| Ascitic fluid | 1 (33) | 1 (33) | 1 (33) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (2) |
| Dialysis fluid | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (1) |
| Other sterile fluids | 0 (0) | (100)2 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (1.4) |
| Pleural fluid | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0.7) |
| Total | 32 (22.5) | 29 (20) | 4 (3) | 17 (12) | 16 (11) | 11 (8) | 10 (7) | 6 (4) | 15 (11) | 1 (0.7) | 1 (0.7) | 142 (100) |
Abbreviations: GNB, gram-negative bacteria; CSF, cerebrospinal fluid.
In vitro antimicrobial resistance of evaluated gram-negative bacteria
| Bacteria | Piperacillin-Tazobactam | Imipenem | Meropenem | Gentamicin | Amikacin | Cefepime | Cefotaxime | Trimethoprim-Sulfamethoxazole | Colistin | Ceftazidime | Ciprofloxacin | Ampicillinsulbactam |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
| 13/31 (42) | 2/6 (33) | 2/3 (67) | 6/31 (19) | 5/31 (16) | 21/32 (66) | 26/32 (81) | 24/32 (75) | – | – | – | – | |
| 16/26 (61.5) | 6/17 (35) | 1/1 (100) | 15/28 (53.5) | 13/28 (46) | 25/29 (86) | 28/29 (96.5) | 19/29 (65.5) | 0/6 (0) | – | – | – | |
| 13/16 (81) | 1/14 (7) | – | 13/13 (100) | 13/16 (81) | 15/16 (94) | 16/16 (100) | 2/16 (12.5) | 0/1 (0) | – | – | – | |
| 1/15 (7) | 2/15 (13) | – | 13/15 (87) | 13/15 (87) | 10/15 (67) | 4/15 (27) | – | – | – | – | – | |
| 1/4 (25) | 0/1 (0) | – | 1/4 (25) | 3/4 (75) | 3/4 (75) | 3/4 (75) | 1/4 (25) | – | – | – | – | |
| 8/10 (80) | 8/10 (80) | – | 8/10 (80) | 8/10 (80) | 8/10 (80) | 10/10 (100) | 8/10 (80) | 0/8 (0) | 8/10 (80) | 7/8 (87.5) | 6/8 (75) | |
| 3/6 (50) | – | – | 1/6 (17) | 0/6 (0) | 3/6 (50) | 4/4 (100) | 1/4 (25) | – | – | – | – | |
| 0/15 (0) | 3/15 (20) | 1/1 (100) | 1/15 (7) | 0/15 (0) | 0/15 (0) | – | – | – | 1/15 (0) | – | – |
Figure 1Genotyping of isolated Acinetobacter baumannii (A), Klebsiella pneumoniae (B), Escherichia coli (C), Pseudomonas aeruginosa (D), and Enterobacter spp. (E) Strains that met hospital-acquired infection criteria.